norm: jade biosciencesNAICS Pharmaceutical Preparations · USno LEI · CIK 0001798749Max severity: Low

Canonical registry

Jade Biosciences, Inc.

ent_019fa1fdf577f6f0ffaf8e9f281b28c7

Compliance scorecard →🔔 Follow entity

Disclosures

1

SEC 10-K Item 1C · 1 jurisdiction

Incidents

—

no linked incident in sample

Max affected reported

—

no filed count in sample

Leak-site claims

0

none in sample

Identity resolution

Canonical name: Jade Biosciences, Inc.
Normalized: jade biosciences— dedupe via name-norm; Microsoft / MSFT collapse to one row
GLEIF LEI: No match
SEC EDGAR CIK: 0001798749
Domain: None on record

Disclosure history (1)newest first

FEDERALSEC 10-K Item 1Cas victim2024-03-25
Item 1C of a 10-K filing describes the registrant's cybersecurity risk management and governance processes. The text outlines internal and external security measures, vendor risk evaluation, and Audit Committee oversight. No specific cybersecurity incident, breach, or material impact is disclosed.